CNS pipeline · person
Elizabeth Garofalo, MD
Director of Xenon Pharmaceuticals since June 2021, principal of EAG Pharma Consulting and former SVP and Global Head of Clinical Development at Novartis with a focus on neuroscience and epilepsy. She holds an M.D. from Indiana University School of Medicine.
- 1 company
Current roles
- Xenon Pharmaceuticals Inc.Director · Board
Appears with
People sharing a company with Elizabeth.
- Andrea DiFabio · Xenon Pharmaceuticals Inc.
- Christopher Kenney · Xenon Pharmaceuticals Inc.
- Darren Cline · Xenon Pharmaceuticals Inc.
- Dawn Svoronos · Xenon Pharmaceuticals Inc.
- Gary Patou · Xenon Pharmaceuticals Inc.
- Gillian Cannon · Xenon Pharmaceuticals Inc.
- Ian Mortimer · Xenon Pharmaceuticals Inc.
- James Empfield · Xenon Pharmaceuticals Inc.
- Justin Gover · Xenon Pharmaceuticals Inc.
- Matthew D. Ronsheim · Xenon Pharmaceuticals Inc.
- Michael Hayden · Xenon Pharmaceuticals Inc.
- Patrick Machado · Xenon Pharmaceuticals Inc.
- Robin Sherrington · Xenon Pharmaceuticals Inc.
- Shelley McCloskey · Xenon Pharmaceuticals Inc.
- Steven Gannon · Xenon Pharmaceuticals Inc.
- Tucker Kelly · Xenon Pharmaceuticals Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.